-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qdn7HEDyrlabwntCe8rOM3o8Ye0KOlfruEUcLAsimc9X5pbyBcVweQs219rmmzD4 CWZk90VDTmps0FVs+rE4Dg== 0000200406-05-000147.txt : 20051121 0000200406-05-000147.hdr.sgml : 20051121 20051121150234 ACCESSION NUMBER: 0000200406-05-000147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051118 FILED AS OF DATE: 20051121 DATE AS OF CHANGE: 20051121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VALERIANI NICHOLAS J CENTRAL INDEX KEY: 0001263149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 051217752 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLAZA STREET 2: C/O JOHNSON & JOHNSON CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0103 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 7325242454 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-11-18 0000200406 JOHNSON & JOHNSON JNJ 0001263149 VALERIANI NICHOLAS J JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 1 0 0 Member, Executive Committee Common 2005-11-18 4 M 0 7600 21.57 A 42607 D Common 2005-11-18 4 S 0 900 62.60 D 41707 D Common 2005-11-18 4 S 0 3900 62.57 D 37807 D Common 8155 I 401(k) and ESOP Savings Plans Common 3146 I As custodian for Son under UTMA Phantom Stock Units Common 0 1196 D Employee Stock Option (Right to Buy) 21.57 2005-11-18 4 M 0 7600 D 1997-11-30 2005-11-30 Common 7600 0 D Adjusted to reflect two-for-one stock splits in 1996 and 2001. Includes 129 shares acquired under the Issuer's Dividend Reinvestment Plan previously unreported. Shares held under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (10/31/2005). The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The Phantom Stock converts into common stock on a one-for-one basis. The Phantom Stock Units held under the Issuer's Executive Income Deferral Plan are to be settled in cash upon the Reporting Person's Retirement. Awarded under Issuer's Stock Option Plan and exercisable in increments of 20% per year starting two years from date of grant. Linda E. King, as Attorney-in-Fact for Nicholas J. Valeriani 2005-11-21 -----END PRIVACY-ENHANCED MESSAGE-----